Your cart is currently empty!
Mirion Medical EC2 Software NMIS BioDose
1. EXECUTIVE SUMMARY
- CVSS v4 8.7
- ATTENTION: Exploitable remotely/low attack complexity
- Vendor: Mirion Medical
- Equipment: EC2 Software NMIS BioDose
- Vulnerabilities: Incorrect Permission Assignment for Critical Resource, Use of Client-Side Authentication, Use of Hard-coded Credentials
2. RISK EVALUATION
Successful exploitation of these vulnerabilities could allow an attacker to modify program executables, gain access to sensitive information, gain unauthorized access to the application, and execute arbitrary code.
3. TECHNICAL DETAILS
3.1 AFFECTED PRODUCTS
The following Mirion Medical products are affected:
- EC2 Software NMIS BioDose: Versions prior to 23.0
3.2 VULNERABILITY OVERVIEW
3.2.1 INCORRECT PERMISSION ASSIGNMENT FOR CRITICAL RESOURCE CWE-732
NMIS/BioDose V22.02 and previous versions’ installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
CVE-2025-64642 has been assigned to this vulnerability. A CVSS v3.1 base score of 8.0 has been calculated; the CVSS vector string is (AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H).
A CVSS v4 score has also been calculated for CVE-2025-64642. A base score of 7.1 has been calculated; the CVSS vector string is (AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N).
3.2.2 INCORRECT PERMISSION ASSIGNMENT FOR CRITICAL RESOURCE CWE-732
NMIS/BioDose V22.02 and previous version installations where the embedded Microsoft SQLServer Express is used are exposed in the Windows share accessed by clients in networked installs. By default, this directory has insecure directory paths that allow access to the SQL Server database and configuration files, which can contain sensitive data.
CVE-2025-64298 has been assigned to this vulnerability. A CVSS v3.1 base score of 8.4 has been calculated; the CVSS vector string is (AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).
A CVSS v4 score has also been calculated for CVE-2025-64298. A base score of 8.6 has been calculated; the CVSS vector string is (AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N).
3.2.3 USE OF CLIENT-SIDE AUTHENTICATION CWE-603
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
CVE-2025-61940 has been assigned to this vulnerability. A CVSS v3.1 base score of 8.3 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L).
A CVSS v4 score has also been calculated for CVE-2025-61940. A base score of 8.7 has been calculated; the CVSS vector string is (AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N).
3.2.4 USE OF HARD-CODED CREDENTIALS CWE-798
NMIS/BioDose software V22.02 and previous versions contain executable binaries with plain text hard-coded passwords. These hard-coded passwords could allow unauthorized access to both the application and database.
CVE-2025-64778 has been assigned to this vulnerability. A CVSS v3.1 base score of 7.3 has been calculated; the CVSS vector string is (AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L).
A CVSS v4 score has also been calculated for CVE-2025-64778. A base score of 8.4 has been calculated; the CVSS vector string is (AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N).
3.2.5 INCORRECT PERMISSION ASSIGNMENT FOR CRITICAL RESOURCE CWE-732
NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account ‘nmdbuser’ and other created accounts by default have the sysadmin role. This can lead to remote code execution through the use of certain built-in stored procedures.
CVE-2025-62575 has been assigned to this vulnerability. A CVSS v3.1 base score of 8.3 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L).
A CVSS v4 score has also been calculated for CVE-2025-62575. A base score of 8.7 has been calculated; the CVSS vector string is (AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N).
3.3 BACKGROUND
- CRITICAL INFRASTRUCTURE SECTORS: Healthcare and Public Health
- COUNTRIES/AREAS DEPLOYED: Worldwide
- COMPANY HEADQUARTERS LOCATION: United States
3.4 RESEARCHER
Joe Dillon reported these vulnerabilities to Mirion Medical.
4. MITIGATIONS
Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support directly.
CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities, such as:
- Minimize network exposure for all control system devices and/or systems, ensuring they are not accessible from the Internet.
- Locate control system networks and remote devices behind firewalls and isolating them from business networks.
- When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as the connected devices.
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets.
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01B–Targeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.
CISA also recommends users take the following measures to protect themselves from social engineering attacks:
- Do not click web links or open attachments in unsolicited email messages.
- Refer to Recognizing and Avoiding Email Scams for more information on avoiding email scams.
- Refer to Avoiding Social Engineering and Phishing Attacks for more information on social engineering attacks.
No known public exploitation specifically targeting these vulnerabilities has been reported to CISA at this time.
5. UPDATE HISTORY
- December 2, 2025: Initial Publication
Leave a Reply